North American Menopause Society (NAMS) video series about important midlife health topics: The Timing Hypothesis of HRT

The North American Menopause Society is proud of its comprehensive video series for clinicians about important midlife health topics. All the interviews in the series are hosted by NAMS Board of Trustees Member and Immediate Past President Dr. Marla Shapiro, a Canadian physician, who led this exciting initiative. Dr. Shapiro is also the medical consultant for CTV News.

In this latest video, The Timing Hypothesis, Dr. Shapiro interviews Dr. Peter Schnatz, Past President of NAMS and Associate Chairman and Residency Program Director in the Department of Obstetrics and Gynecology at the Reading Hospital in Reading, Pennsylvania. Dr. Schnatz discusses the benefits of starting women on hormone therapy at the beginning of the menopause transition, along with the cardiovascular health advantages.   

The ELITE:Early Versus Late Intervention Trial With Estradiol also affirms the timing hypothesis in relation to timing of estradiol administration, when a beneficial cardiovascular effect is only seen in women with early, but not later menopause.